Altium Capital Management LLC
Follow13F filer, CIK 1746382, NEW YORK, NY
Altium Capital Management LLC reported $41,500,012 across 24 holdings for the quarter ended 2025-03-31, in a 13F-HR/A filed 2025-05-13. Its ten largest share positions make up 87.51% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR/A 0001420506-25-000988
- Period
- 2025-03-31
- Reported value
- $41.5M
- Holdings
- 24
- Top 10 weight
- 87.51%
- New
- 6
- Sold out
- 49
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| INTELLIGENT BIO SOLUTIONS INnew | +149,252 | $215K |
| KPTInew | +49,333 | $185K |
| SHARPS TECHNOLOGY INCnew | +4,044,149 | $110K |
| LOGICMARK INCnew | +5,395,308 | $107K |
| SBFMnew | +50,466 | $96.4K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| ADMAexited | -1,395,000 | -$23.9M |
| VERAexited | -432,000 | -$18.3M |
| SRPTexited | -127,000 | -$15.4M |
| ESTAexited | -305,000 | -$14.1M |
| EWexited | -165,000 | -$12.2M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q1 2025
Share positions as resolved from 13F-HR/A 0001420506-25-000988, largest first. % of portfolio is the value over $34,434,142, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ZVRAZEVRA THERAPEUTICS INC | 1,287,333 | $9.64M | 28% | -562,667 | Timeline | ||
| EOLSEVOLUS INC | 296,193 | $3.56M | 10.35% | -388,807 | Timeline | ||
| XTNTXTANT MED HLDGS INC | 7,252,998 | $3.41M | 9.9% | -162,415 | Timeline | ||
| AVADEL PHARMACEUTICALSAVADEL PHARMACEUTICALS | 419,131 | $3.28M | 9.53% | -33,344 | |||
| CTNMCONTINEUM THERAPEUTICS INC | 303,857 | $2.12M | 6.16% | -30,143 | Timeline | ||
| PROFPROFOUND MED CORP | 360,589 | $2.1M | 6.09% | -124,411 | Timeline | ||
| XENEXENON PHARMACEUTICALS INC | 60,251 | $2.02M | 5.87% | -227,749 | Timeline | ||
| ESSA PHARMA INCESSA PHARMA INC | 1,050,369 | $1.66M | 4.82% | -377,631 | |||
| SKYESKYE BIOSCIENCE INC | 904,865 | $1.44M | 4.18% | -234,135 | Timeline | ||
| ACOGALPHA COGNITION INC | 177,416 | $898K | 2.61% | -97,584 | Timeline | ||
| RZLTREZOLUTE INC | 303,949 | $881K | 2.56% | -1,390,051 | Timeline | ||
| NEKTAR THERAPEUTICSNEKTAR THERAPEUTICS | 1,051,379 | $715K | 2.08% | -1,948,621 | |||
| AVRANTERIS TECHNOLOGIES GLOBAL | 168,589 | $614K | 1.78% | -568,411 | Timeline | ||
| LRMRLARIMAR THERAPEUTICS INC | 273,204 | $587K | 1.71% | -231,796 | Timeline | ||
| PROMIS NEUROSCIENCES INCPROMIS NEUROSCIENCES INC | 574,248 | $399K | 1.16% | -7,147 | |||
| ENVVENO MEDICAL CORPORATIONENVVENO MEDICAL CORPORATION | 123,256 | $324K | 0.94% | -186,744 | |||
| INTELLIGENT BIO SOLUTIONS ININTELLIGENT BIO SOLUTIONS IN | 149,252 | $215K | 0.62% | new | |||
| KPTIKARYOPHARM THERAPEUTICS INC | 49,333 | $185K | 0.54% | new | Timeline | ||
| SHARPS TECHNOLOGY INCSHARPS TECHNOLOGY INC | 4,044,149 | $110K | 0.32% | new | |||
| LOGICMARK INCLOGICMARK INC | 5,395,308 | $107K | 0.31% | new | |||
| SBFMSUNSHINE BIOPHARMA INC | 50,466 | $96.4K | 0.28% | new | Timeline | ||
| SRXHSRX GLOBAL INC | 38,984 | $67.1K | 0.19% | -79,475 | Timeline |
Options
Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).
Sold out in Q1 2025
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| ADMAADMA BIOLOGICS INC | 1,395,000 | $23.9M | shares |
| VERAVERA THERAPEUTICS INC | 432,000 | $18.3M | shares |
| SRPTSAREPTA THERAPEUTICS INC | 127,000 | $15.4M | shares |
| ESTAESTABLISHMENT LABS HLDGS INC | 305,000 | $14.1M | shares |
| ESTAESTABLISHMENT LABS HLDGS INC | 300,000 | $13.8M | call |
| SRRKSCHOLAR ROCK HLDG CORP | 300,000 | $13M | call |
| EWEDWARDS LIFESCIENCES CORP | 165,000 | $12.2M | shares |
| SLNOSOLENO THERAPEUTICS INC | 250,000 | $11.2M | shares |
| CAPRCAPRICOR THERAPEUTICS INC | 714,000 | $9.85M | shares |
| RXSTRXSIGHT INC | 285,000 | $9.8M | shares |
| MMSIMERIT MED SYS INC | 100,000 | $9.67M | shares |
| BHVNBIOHAVEN LTD | 250,000 | $9.34M | shares |
| INSMINSMED INC | 132,000 | $9.11M | shares |
| INTRA-CELLULAR THERAPIES INCINTRA-CELLULAR THERAPIES INC | 75,000 | $6.26M | shares |
| ARGXARGENX SE | 10,000 | $6.15M | shares |
| GKOSGLAUKOS CORP | 40,000 | $6M | shares |
| RMDRESMED INC | 26,000 | $5.95M | shares |
| VKTXVIKING THERAPEUTICS INC | 146,000 | $5.88M | shares |
| EXASEXACT SCIENCES CORP | 100,000 | $5.62M | shares |
| LUNGPULMONX CORP | 815,000 | $5.53M | shares |
| CMPSCOMPASS PATHWAYS PLC | 1,424,400 | $5.38M | shares |
| CPRXCATALYST PHARMACEUTICALS INC | 255,000 | $5.32M | shares |
| SNDXSYNDAX PHARMACEUTICALS INC | 370,000 | $4.89M | shares |
| SVRASAVARA INC | 1,579,000 | $4.85M | shares |
| CRBPCORBUS PHARMACEUTICALS HLDGS | 385,000 | $4.54M | shares |
| ARWRARROWHEAD PHARMACEUTICALS IN | 230,257 | $4.33M | shares |
| ORICORIC PHARMACEUTICALS INC | 355,000 | $2.86M | shares |
| TGTXTG THERAPEUTICS INC | 95,000 | $2.86M | shares |
| KROSKEROS THERAPEUTICS INC | 175,000 | $2.77M | shares |
| ANABANAPTYSBIO INC | 206,200 | $2.73M | put |
| IBRXIMMUNITYBIO INC | 1,060,000 | $2.71M | shares |
| LXEOLEXEO THERAPEUTICS INC | 405,000 | $2.66M | shares |
| TERNTERNS PHARMACEUTICALS INC | 475,000 | $2.63M | shares |
| RVMDREVOLUTION MEDICINES INC | 60,000 | $2.62M | shares |
| ATECALPHATEC HLDGS INC | 264,562 | $2.43M | shares |
| OKURONKURE THERAPEUTICS INC | 218,386 | $1.88M | shares |
| LRMRLARIMAR THERAPEUTICS INC | 396,000 | $1.53M | call |
| PRQRPROQR THRAPEUTICS N V | 575,000 | $1.52M | shares |
| Veru IncVeru Inc | 2,028,534 | $1.32M | shares |
| UNICYCIVE THERAPEUTICS INCUNICYCIVE THERAPEUTICS INC | 1,473,000 | $1.17M | shares |
| BCYCBICYCLE THERAPEUTICS PLC | 40,352 | $565K | shares |
| FULCFULCRUM THERAPEUTICS INC | 111,812 | $526K | shares |
| KARYOPHARM THERAPEUTICS INCKARYOPHARM THERAPEUTICS INC | 740,000 | $500K | shares |
| CTMXCYTOMX THERAPEUTICS INC. | 467,491 | $482K | shares |
| CATXPERSPECTIVE THERAPEUTICS INC | 92,224 | $294K | shares |
| ANABANAPTYSBIO INC | 18,326 | $243K | shares |
| QUOIN PHARMACEUTICALS ADRQUOIN PHARMACEUTICALS ADR | 282,249 | $184K | shares |
| CELLECTAR BIOSCIENCES INCCELLECTAR BIOSCIENCES INC | 215,000 | $64.3K | shares |
| Applied Therapeutics IncApplied Therapeutics Inc | 56,100 | $48K | put |
How Q1 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001420506-25-000948 | superseded | 2025-05-09 | acceptance time not in the bulk data set | ||
| 13F-HR/A 0001420506-25-000988 | base | restatement | 2025-05-13 | acceptance time not in the bulk data set |